JP2025518227A5 - - Google Patents

Info

Publication number
JP2025518227A5
JP2025518227A5 JP2024570699A JP2024570699A JP2025518227A5 JP 2025518227 A5 JP2025518227 A5 JP 2025518227A5 JP 2024570699 A JP2024570699 A JP 2024570699A JP 2024570699 A JP2024570699 A JP 2024570699A JP 2025518227 A5 JP2025518227 A5 JP 2025518227A5
Authority
JP
Japan
Prior art keywords
approximately
weeks
mazdutide
pharmaceutically acceptable
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024570699A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025518227A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2023/093311 external-priority patent/WO2023231730A2/zh
Publication of JP2025518227A publication Critical patent/JP2025518227A/ja
Publication of JP2025518227A5 publication Critical patent/JP2025518227A5/ja
Pending legal-status Critical Current

Links

JP2024570699A 2022-06-01 2023-05-10 mazdutideを使用する治療方法 Pending JP2025518227A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN202210622648.7 2022-06-01
CN202210622648 2022-06-01
PCT/CN2023/093311 WO2023231730A2 (zh) 2022-06-01 2023-05-10 使用mazdutide的治疗方法

Publications (2)

Publication Number Publication Date
JP2025518227A JP2025518227A (ja) 2025-06-12
JP2025518227A5 true JP2025518227A5 (cg-RX-API-DMAC7.html) 2026-05-15

Family

ID=89026916

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024570699A Pending JP2025518227A (ja) 2022-06-01 2023-05-10 mazdutideを使用する治療方法

Country Status (8)

Country Link
US (1) US20250296973A1 (cg-RX-API-DMAC7.html)
EP (1) EP4534095A4 (cg-RX-API-DMAC7.html)
JP (1) JP2025518227A (cg-RX-API-DMAC7.html)
KR (1) KR20250021331A (cg-RX-API-DMAC7.html)
CN (1) CN119584980A (cg-RX-API-DMAC7.html)
AU (1) AU2023281591A1 (cg-RX-API-DMAC7.html)
CA (1) CA3257926A1 (cg-RX-API-DMAC7.html)
WO (1) WO2023231730A2 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202617173A (zh) * 2021-06-25 2026-05-01 大陸商信達生物製藥(蘇州)有限公司 Mazdutide的應用
EP4788362A1 (en) * 2023-10-03 2026-08-12 Innovent Biologics (Suzhou) Co., Ltd. Methods of treating diabetes and obesity
WO2026002224A1 (en) * 2024-06-27 2026-01-02 Innovent Biologics (Suzhou) Co., Ltd. Method of treating polycystic ovary syndrome

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI783244B (zh) * 2015-06-22 2022-11-11 美商美國禮來大藥廠 升糖素及glp-1共激動劑化合物
US11419918B2 (en) * 2017-11-06 2022-08-23 Shenzhen Turier Biotech Co., Ltd. Treatment of biliary cirrhosis based on oxyntomodulin analogue GLP-1R/GCGR dual-target agonist peptide
CN111423506B (zh) * 2019-11-08 2023-06-27 成都奥达生物科技有限公司 一种glp-1化合物
TW202617173A (zh) * 2021-06-25 2026-05-01 大陸商信達生物製藥(蘇州)有限公司 Mazdutide的應用

Similar Documents

Publication Publication Date Title
Krasagakis et al. Management of severe scleroderma with long-term extracorporeal photopheresis
TWI455723B (zh) 納曲酮及安非他酮於治療超重或肥胖病患之用途
JP2021193148A5 (cg-RX-API-DMAC7.html)
JP2009503020A5 (cg-RX-API-DMAC7.html)
JP2024527023A5 (cg-RX-API-DMAC7.html)
JP2023552700A5 (cg-RX-API-DMAC7.html)
CN1248170A (zh) 含人体生长激素和皮质甾醇合成抑制剂的用于治疗代谢综合症的制剂
JP2025518227A (ja) mazdutideを使用する治療方法
AU2009304002B9 (en) A medicinal product and treatment
CN107137417B (zh) 一种用于治疗恶病质的药物组合物及其应用
WO2024042518A1 (en) Glp-1 receptor antagonist and methods of use thereof
EP1274414A1 (en) Nasal administration of agents for the treatment of gastroparesis
JP2026016423A (ja) Glp-1の投薬レジメン
JP2022058873A5 (cg-RX-API-DMAC7.html)
JP2025060703A5 (cg-RX-API-DMAC7.html)
WO2024078507A1 (zh) 麦角甾醇在制备防治胃溃疡药物中的应用
JP5034944B2 (ja) インターフェロン作用物質の活性増強剤
JPS5998018A (ja) 老化治療剤
JP2021169472A5 (cg-RX-API-DMAC7.html)
CN116019801B (zh) 用于促进内源性生长激素分泌的氨基酸组合物
RU2024126016A (ru) Лечение глиомы низкой степени злокачественности мирдаметинибом
CN117243948A (zh) 包含瑞香素的组合物在制备风湿性关节炎药物中的应用
CN121648265A (zh) 司美格鲁肽与丁酸钠联用在制备用于减重的药物中的应用
JPH06234642A (ja) 有機化合物に関する改良
JP2026500731A (ja) 医薬組合せおよび医薬組成物、ならびにその使用方法